The areas of greatest opportunity in medtech are those which have already demonstrated they have plenty of upside, even if a robust number of competitors have already begun targeting them. Areas of the strongest market growth in medical technologies that we are seeing have emerged out of the major segments we have tracked in recent [...]
Regularly updated list of venture capitalists investing in healthcare. Links to portfolio pages. bookmark to
Medical technology startup companies that we identified during the month of October 2009 are developing the following specific technologies: Diagnostic imaging in urology and oncology. Endoscopic tissue management technology. Esophageal monitoring device to replace peripheral artery catheter. Products for treatment of fecal incontinence and GERD. Surgical instrumentation to reduce trauma of surgery. Suction device for [...]
Medical technology financings for the month of October stood at $202 million, marking the third month in a row that financings have declined, from a high in 2009 of $440 million in July. See financings by month for September, August and July and for 2009 trend. We track medical technology, in our biased definition, as medical [...]
This is a "work in progress", partial list of medical technology incubators, defined as such by themselves or by the nature of their more active involvement (beyond funding) in the nuturing and development of "portfolio" companies — providing space, management and other support. Also, note that these are entities whose focus is primarily or exclusively [...]
Medtech investment in October has risen to only $164 million (see link), off from the pace in third quarter. Data on overall venture investment was reported in Money Tree Report by PricewaterhouseCoopers and the National Venture Capital Association reflecting a still-gloomy aggregate for investment. Overall venture investment in Q3 stood at 5.1 billion compared to $8.2 [...]
Recent data from VentureSource (we noted in our post on the medtech impact) show the decline in venture capital financing in 3Q 2009. There is, of course, a natural outcome that can be expected when there are well established medtech businesses with existing product lines (and cash flows) but seeking growth, while there simultaneously exist [...]
Signs that VC investment are at a six-year low came out of a recent Dow Jones VentureSource report. However, as one would expect, medical technology has fared better than the average for aggregate VC investment, with medtech drawing investment in recent months in excess of $400 million per month (see medtech financings by month, 2009). [...]
Third quarter 2009 financing results from Abbott and Baxter were made public this week. Baxter’s 3Q profit rose 12%. Abbott Labs’ 3Q profit rose 37% (coming at the expense of Medtronic in a patent dispute settlement). Boston Scientific’s 2Q profit at mid-year were up 61%. Meanwhile, smaller medtech companies (see WSJ’s Turning out the Lights) [...]
Below is a brief profile of Adhezion Biomedical, LLC, one of the companies active in the surgical sealants and glues market and profiled in the MedMarket Diligence report #S175. We occasionally highlight companies whose products, in our opinion, are poised to make an impact on medtech markets. Founded in 2001, Adhezion Biomedical (formerly Spartan Medical [...]
Contact:
